$42.35
1.46% day before yesterday
NYSE, Nov 01, 09:00 pm CET
ISIN
US26622P1075
Symbol
DOCS

Doximity Stock price

$42.35
-0.85 1.97% 1M
+18.34 76.38% 6M
+14.31 51.03% YTD
+22.02 108.31% 1Y
-31.38 42.56% 3Y
-10.65 20.09% 5Y
-10.65 20.09% 10Y
NYSE, Closing price Fri, Nov 01 2024
+0.61 1.46%
ISIN
US26622P1075
Symbol
DOCS

Key metrics

Market capitalization $7.86b
Enterprise Value $7.13b
P/E (TTM) P/E ratio 53.25
EV/FCF (TTM) EV/FCF 43.94
EV/Sales (TTM) EV/Sales 14.44
P/S ratio (TTM) P/S ratio 15.93
P/B ratio (TTM) P/B ratio 8.61
Revenue growth (TTM) Revenue growth 12.99%
Revenue (TTM) Revenue $493.63m
EBIT (operating result TTM) EBIT $189.07m
Free Cash Flow (TTM) Free Cash Flow $162.20m
Cash position $750.49m
EPS (TTM) EPS $0.80
P/E forward 55.35
P/S forward 15.12
EV/Sales forward 13.70
Short interest 8.58%
Show more

Is Doximity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Doximity Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Doximity forecast:

8x Buy
44%
8x Hold
44%
2x Sell
11%

Analyst Opinions

18 Analysts have issued a Doximity forecast:

Buy
44%
Hold
44%
Sell
11%

Financial data from Doximity

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
494 494
13% 13%
100%
- Direct Costs 51 51
5% 5%
10%
443 443
15% 15%
90%
- Selling and Administrative Expenses 160 160
4% 4%
32%
- Research and Development Expense 83 83
1% 1%
17%
200 200
36% 36%
40%
- Depreciation and Amortization 11 11
15% 15%
2%
EBIT (Operating Income) EBIT 189 189
41% 41%
38%
Net Profit 161 161
35% 35%
33%

In millions USD.

Don't miss a Thing! We will send you all news about Doximity directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Doximity Stock News

Positive
Investors Business Daily
3 days ago
This telehealth technology provider is holding above its 50-day moving average. The company reports its next earnings on Nov. 7.
Neutral
Business Wire
17 days ago
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2024 after market close on November 7, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a liv...
Neutral
Business Wire
27 days ago
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the leadership of Doximity, Inc. (“Doximity”) (NYSE: DOCS) breached their fiduciary duties to Doximity and its shareholders. CLICK HERE TO LEARN MORE Scott+Scott is investigating whether members of Doximity's board of directors or...
More Doximity News

Company Profile

Doximity, Inc. operates an online platform for medical professionals. It's cloud-based software has the ability to enable the users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. The company was founded by Konstantin Guericke, Nate Gross and Jeffrey A. Tangney in April 16, 2010 and is headquartered in San Francisco, CA.

Head office United States
CEO Jeffrey Tangney
Employees 827
Founded 2010
Website www.doximity.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today